BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3490908)

  • 1. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
    Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
    Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3.
    Morel PA; Manolagas SC; Provvedini DM; Wegmann DR; Chiller JM
    J Immunol; 1986 Mar; 136(6):2181-6. PubMed ID: 3005406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of human myeloid leukemia cell line ML-1 induced by retinoic acid and 1,25-dihydroxyvitamin D3.
    Haskovec C; Lemez P; Neuwirtová R; Wilhelm J; Jarolím P
    Neoplasma; 1990; 37(5):565-72. PubMed ID: 1700313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
    Bettens F; Schlick E; Farrar W; Ruscetti F
    J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,25-dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells.
    Suematsu Y; Nishizawa Y; Shioi A; Hino M; Tahara H; Inaba M; Morii H; Otani S
    J Cell Physiol; 1995 Dec; 165(3):547-55. PubMed ID: 7593234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3.
    Goldman R
    Cancer Res; 1984 Jan; 44(1):11-9. PubMed ID: 6546302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
    Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of NaF-induced differentiation of HL-60 cells.
    Kawase T; Oguro A; Orikasa M; Burns DM
    J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.
    Studzinski GP; Bhandal AK; Brelvi ZS
    Cancer Res; 1985 Aug; 45(8):3898-905. PubMed ID: 3860289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the effect of 1,25-dihydroxycholecalciferol on the proliferation and differentiation of the human promyelocytic leukaemia cell line HL-60.
    Djulbegović B; Christmas SE; Evans G; Moore M
    Biomed Pharmacother; 1986; 40(10):407-16. PubMed ID: 3472610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.